APO Research
Talk to an analyst

APO RESEARCH · REPORT

Opioid Induced Constipation (OIC) Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Opioid Induced Constipation (OIC) Drug Market Analysis and Forecast 2026-2032

20 December 2025202 pages

Choose your research edition.

Industry ResearchOpioid Induced Constipation (OIC) Drug Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Opioid Induced Constipation (OIC) Drug Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Opioid Induced Constipation (OIC) Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Opioid Induced Constipation (OIC) Drug Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Opioid Induced Constipation (OIC) Drug Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Opioid Induced Constipation (OIC) Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Opioid Induced Constipation (OIC) Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Opioid Induced Constipation (OIC) Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Opioid Induced Constipation (OIC) Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Opioid Induced Constipation (OIC) Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Opioid Induced Constipation (OIC) Drug include Allergan, Bausch Health, C.B. Fleet Company, Cosmo Pharmaceuticals SA, Daewoong Pharmaceutical, Daiichi Sankyo Co, Ironwood Pharmaceuticals, Mundipharma International Limited and Nektar Therapeutics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Opioid Induced Constipation (OIC) Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Opioid Induced Constipation (OIC) Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Opioid Induced Constipation (OIC) Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Opioid Induced Constipation (OIC) Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Opioid Induced Constipation (OIC) Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Opioid Induced Constipation (OIC) Drug sales, projected growth trends, production technology, application and end-user industry.

Opioid Induced Constipation (OIC) Drug Segment by Company

Allergan

Bausch Health

C.B. Fleet Company

Cosmo Pharmaceuticals SA

Daewoong Pharmaceutical

Daiichi Sankyo Co

Ironwood Pharmaceuticals

Mundipharma International Limited

Nektar Therapeutics

Ono Pharmaceutical

Progenics Pharmaceuticals

Purdue Pharma

S.L.A. Pharma

Shionogi &

Sucampo Pharmaceuticals

Theravance Biopharma

Pfizer

Takeda Pharmaceutical Company Limited

Opioid Induced Constipation (OIC) Drug Segment by Type

Naldemedine

Lubiprostone

Methyl Naltrexone Bromide

Alvimopan

Other

Opioid Induced Constipation (OIC) Drug Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Opioid Induced Constipation (OIC) Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Opioid Induced Constipation (OIC) Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Opioid Induced Constipation (OIC) Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Opioid Induced Constipation (OIC) Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Opioid Induced Constipation (OIC) Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Opioid Induced Constipation (OIC) Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Opioid Induced Constipation (OIC) Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Opioid Induced Constipation (OIC) Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Naldemedine Major Manufacturers Table 3. Lubiprostone Major Manufacturers Table 4. Methyl Naltrexone Bromide Major Manufacturers Table 5. Alvimopan Major Manufacturers Table 6. Other Major Manufacturers Table 7. Global Opioid Induced Constipation (OIC) Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Retail Pharmacies Major Manufacturers Table 9. Online Pharmacies Major Manufacturers Table 10. Hospital Pharmacies Major Manufacturers Table 11. Opioid Induced Constipation (OIC) Drug Industry Trends Table 12. Opioid Induced Constipation (OIC) Drug Industry Drivers Table 13. Opioid Induced Constipation (OIC) Drug Industry Opportunities and Challenges Table 14. Opioid Induced Constipation (OIC) Drug Industry Restraints Table 15. Global Opioid Induced Constipation (OIC) Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Opioid Induced Constipation (OIC) Drug Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Opioid Induced Constipation (OIC) Drug Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region (2021-2026) Table 19. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region (2027-2032) Table 20. Global Opioid Induced Constipation (OIC) Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 21. Global Opioid Induced Constipation (OIC) Drug Sales by Region (2021-2026) & (K Units) Table 22. Global Opioid Induced Constipation (OIC) Drug Sales by Region (2027-2032) & (K Units) Table 23. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2021-2026) Table 24. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2027-2032) Table 25. Global Opioid Induced Constipation (OIC) Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Opioid Induced Constipation (OIC) Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Manufacturers (2021-2026) Table 29. Global Opioid Induced Constipation (OIC) Drug Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global Opioid Induced Constipation (OIC) Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Opioid Induced Constipation (OIC) Drug Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Opioid Induced Constipation (OIC) Drug Manufacturers, Product Type & Application Table 33. Global Opioid Induced Constipation (OIC) Drug Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Opioid Induced Constipation (OIC) Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Opioid Induced Constipation (OIC) Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Opioid Induced Constipation (OIC) Drug Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Opioid Induced Constipation (OIC) Drug Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type (2021-2026) Table 40. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type (2027-2032) Table 41. Global Opioid Induced Constipation (OIC) Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 42. Global Opioid Induced Constipation (OIC) Drug Sales by Type (2021-2026) & (K Units) Table 43. Global Opioid Induced Constipation (OIC) Drug Sales by Type (2027-2032) & (K Units) Table 44. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2021-2026) Table 45. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2027-2032) Table 46. Global Opioid Induced Constipation (OIC) Drug Price by Type (2021-2026) & (US$/Unit) Table 47. Global Opioid Induced Constipation (OIC) Drug Price by Type (2027-2032) & (US$/Unit) Table 48. Global Opioid Induced Constipation (OIC) Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Opioid Induced Constipation (OIC) Drug Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Opioid Induced Constipation (OIC) Drug Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Application (2021-2026) Table 52. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Application (2027-2032) Table 53. Global Opioid Induced Constipation (OIC) Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 54. Global Opioid Induced Constipation (OIC) Drug Sales by Application (2021-2026) & (K Units) Table 55. Global Opioid Induced Constipation (OIC) Drug Sales by Application (2027-2032) & (K Units) Table 56. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2021-2026) Table 57. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2027-2032) Table 58. Global Opioid Induced Constipation (OIC) Drug Price by Application (2021-2026) & (US$/Unit) Table 59. Global Opioid Induced Constipation (OIC) Drug Price by Application (2027-2032) & (US$/Unit) Table 60. Allergan Company Information Table 61. Allergan Business Overview Table 62. Allergan Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. Allergan Opioid Induced Constipation (OIC) Drug Product Portfolio Table 64. Allergan Recent Development Table 65. Bausch Health Company Information Table 66. Bausch Health Business Overview Table 67. Bausch Health Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Bausch Health Opioid Induced Constipation (OIC) Drug Product Portfolio Table 69. Bausch Health Recent Development Table 70. C.B. Fleet Company Company Information Table 71. C.B. Fleet Company Business Overview Table 72. C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Product Portfolio Table 74. C.B. Fleet Company Recent Development Table 75. Cosmo Pharmaceuticals SA Company Information Table 76. Cosmo Pharmaceuticals SA Business Overview Table 77. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Product Portfolio Table 79. Cosmo Pharmaceuticals SA Recent Development Table 80. Daewoong Pharmaceutical Company Information Table 81. Daewoong Pharmaceutical Business Overview Table 82. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Portfolio Table 84. Daewoong Pharmaceutical Recent Development Table 85. Daiichi Sankyo Co Company Information Table 86. Daiichi Sankyo Co Business Overview Table 87. Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Product Portfolio Table 89. Daiichi Sankyo Co Recent Development Table 90. Ironwood Pharmaceuticals Company Information Table 91. Ironwood Pharmaceuticals Business Overview Table 92. Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Portfolio Table 94. Ironwood Pharmaceuticals Recent Development Table 95. Mundipharma International Limited Company Information Table 96. Mundipharma International Limited Business Overview Table 97. Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Product Portfolio Table 99. Mundipharma International Limited Recent Development Table 100. Nektar Therapeutics Company Information Table 101. Nektar Therapeutics Business Overview Table 102. Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Product Portfolio Table 104. Nektar Therapeutics Recent Development Table 105. Ono Pharmaceutical Company Information Table 106. Ono Pharmaceutical Business Overview Table 107. Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Portfolio Table 109. Ono Pharmaceutical Recent Development Table 110. Progenics Pharmaceuticals Company Information Table 111. Progenics Pharmaceuticals Business Overview Table 112. Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Portfolio Table 114. Progenics Pharmaceuticals Recent Development Table 115. Purdue Pharma Company Information Table 116. Purdue Pharma Business Overview Table 117. Purdue Pharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Purdue Pharma Opioid Induced Constipation (OIC) Drug Product Portfolio Table 119. Purdue Pharma Recent Development Table 120. S.L.A. Pharma Company Information Table 121. S.L.A. Pharma Business Overview Table 122. S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Product Portfolio Table 124. S.L.A. Pharma Recent Development Table 125. Shionogi & Company Information Table 126. Shionogi & Business Overview Table 127. Shionogi & Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Shionogi & Opioid Induced Constipation (OIC) Drug Product Portfolio Table 129. Shionogi & Recent Development Table 130. Sucampo Pharmaceuticals Company Information Table 131. Sucampo Pharmaceuticals Business Overview Table 132. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Portfolio Table 134. Sucampo Pharmaceuticals Recent Development Table 135. Theravance Biopharma Company Information Table 136. Theravance Biopharma Business Overview Table 137. Theravance Biopharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. Theravance Biopharma Opioid Induced Constipation (OIC) Drug Product Portfolio Table 139. Theravance Biopharma Recent Development Table 140. Pfizer Company Information Table 141. Pfizer Business Overview Table 142. Pfizer Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 143. Pfizer Opioid Induced Constipation (OIC) Drug Product Portfolio Table 144. Pfizer Recent Development Table 145. Takeda Pharmaceutical Company Limited Company Information Table 146. Takeda Pharmaceutical Company Limited Business Overview Table 147. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 148. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Product Portfolio Table 149. Takeda Pharmaceutical Company Limited Recent Development Table 150. North America Opioid Induced Constipation (OIC) Drug Revenue by Type (2021-2026) & (US$ Million) Table 151. North America Opioid Induced Constipation (OIC) Drug Revenue by Type (2027-2032) & (US$ Million) Table 152. North America Opioid Induced Constipation (OIC) Drug Sales by Type (2021-2026) & (K Units) Table 153. North America Opioid Induced Constipation (OIC) Drug Sales by Type (2027-2032) & (K Units) Table 154. North America Opioid Induced Constipation (OIC) Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 155. North America Opioid Induced Constipation (OIC) Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 156. North America Opioid Induced Constipation (OIC) Drug Revenue by Application (2021-2026) & (US$ Million) Table 157. North America Opioid Induced Constipation (OIC) Drug Revenue by Application (2027-2032) & (US$ Million) Table 158. North America Opioid Induced Constipation (OIC) Drug Sales by Application (2021-2026) & (K Units) Table 159. North America Opioid Induced Constipation (OIC) Drug Sales by Application (2027-2032) & (K Units) Table 160. North America Opioid Induced Constipation (OIC) Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 161. North America Opioid Induced Constipation (OIC) Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 162. North America Opioid Induced Constipation (OIC) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 163. North America Opioid Induced Constipation (OIC) Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 164. North America Opioid Induced Constipation (OIC) Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 165. North America Opioid Induced Constipation (OIC) Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 166. North America Opioid Induced Constipation (OIC) Drug Sales by Country (2021-2026) & (K Units) Table 167. North America Opioid Induced Constipation (OIC) Drug Sales by Country (2027-2032) & (K Units) Table 168. North America Opioid Induced Constipation (OIC) Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 169. North America Opioid Induced Constipation (OIC) Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 170. United States Opioid Induced Constipation (OIC) Drug Revenue (2021-2032) & (US$ Million) Table 171. Canada Opioid Induced Constipation (OIC) Drug Revenue (2021-2032) & (US$ Million) Table 172. Europe Opioid Induced Constipation (OIC) Drug Revenue by Type (2021-2026) & (US$ Million) Table 173. Europe Opioid Induced Constipation (OIC) Drug Revenue by Type (2027-2032) & (US$ Million) Table 174. Europe Opioid Induced Constipation (OIC) Drug Sales by Type (2021-2026) & (K Units) Table 175. Europe Opioid Induced Constipation (OIC) Drug Sales by Type (2027-2032) & (K Units) Table 176. Europe Opioid Induced Constipation (OIC) Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 177. Europe Opioid Induced Constipation (OIC) Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 178. Europe Opioid Induced Constipation (OIC) Drug Revenue by Application (2021-2026) & (US$ Million) Table 179. Europe Opioid Induced Constipation (OIC) Drug Revenue by Application (2027-2032) & (US$ Million) Table 180. Europe Opioid Induced Constipation (OIC) Drug Sales by Application (2021-2026) & (K Units) Table 181. Europe Opioid Induced Constipation (OIC) Drug Sales by Application (2027-2032) & (K Units) Table 182. Europe Opioid Induced Constipation (OIC) Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 183. Europe Opioid Induced Constipation (OIC) Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 184. Europe Opioid Induced Constipation (OIC) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. Europe Opioid Induced Constipation (OIC) Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. Europe Opioid Induced Constipation (OIC) Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. Europe Opioid Induced Constipation (OIC) Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 188. Europe Opioid Induced Constipation (OIC) Drug Sales by Country (2021-2026) & (K Units) Table 189. Europe Opioid Induced Constipation (OIC) Drug Sales by Country (2027-2032) & (K Units) Table 190. Europe Opioid Induced Constipation (OIC) Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 191. Europe Opioid Induced Constipation (OIC) Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 192. Germany Opioid Induced Constipation (OIC) Drug Revenue (2021-2032) & (US$ Million) Table 193. France Opioid Induced Constipation (OIC) Drug Revenue (2021-2032) & (US$ Million) Table 194. U.K. Opioid Induced Constipation (OIC) Drug Revenue (2021-2032) & (US$ Million) Table 195. Italy Opioid Induced Constipation (OIC) Drug Revenue (2021-2032) & (US$ Million) Table 196. Netherlands Opioid Induced Constipation (OIC) Drug Revenue (2021-2032) & (US$ Million) Table 197. China Opioid Induced Constipation (OIC) Drug Revenue by Type (2021-2026) & (US$ Million) Table 198. China Opioid Induced Constipation (OIC) Drug Revenue by Type (2027-2032) & (US$ Million) Table 199. China Opioid Induced Constipation (OIC) Drug Sales by Type (2021-2026) & (K Units) Table 200. China Opioid Induced Constipation (OIC) Drug Sales by Type (2027-2032) & (K Units) Table 201. China Opioid Induced Constipation (OIC) Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 202. China Opioid Induced Constipation (OIC) Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 203. China Opioid Induced Constipation (OIC) Drug Revenue by Application (2021-2026) & (US$ Million) Table 204. China Opioid Induced Constipation (OIC) Drug Revenue by Application (2027-2032) & (US$ Million) Table 205. China Opioid Induced Constipation (OIC) Drug Sales by Application (2021-2026) & (K Units) Table 206. China Opioid Induced Constipation (OIC) Drug Sales by Application (2027-2032) & (K Units) Table 207. China Opioid Induced Constipation (OIC) Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 208. China Opioid Induced Constipation (OIC) Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 209. Asia Opioid Induced Constipation (OIC) Drug Revenue by Type (2021-2026) & (US$ Million) Table 210. Asia Opioid Induced Constipation (OIC) Drug Revenue by Type (2027-2032) & (US$ Million) Table 211. Asia Opioid Induced Constipation (OIC) Drug Sales by Type (2021-2026) & (K Units) Table 212. Asia Opioid Induced Constipation (OIC) Drug Sales by Type (2027-2032) & (K Units) Table 213. Asia Opioid Induced Constipation (OIC) Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 214. Asia Opioid Induced Constipation (OIC) Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 215. Asia Opioid Induced Constipation (OIC) Drug Revenue by Application (2021-2026) & (US$ Million) Table 216. Asia Opioid Induced Constipation (OIC) Drug Revenue by Application (2027-2032) & (US$ Million) Table 217. Asia Opioid Induced Constipation (OIC) Drug Sales by Application (2021-2026) & (K Units) Table 218. Asia Opioid Induced Constipation (OIC) Drug Sales by Application (2027-2032) & (K Units) Table 219. Asia Opioid Induced Constipation (OIC) Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 220. Asia Opioid Induced Constipation (OIC) Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 221. Asia Opioid Induced Constipation (OIC) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 222. Asia Opioid Induced Constipation (OIC) Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 223. Asia Opioid Induced Constipation (OIC) Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 224. Asia Opioid Induced Constipation (OIC) Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 225. Asia Opioid Induced Constipation (OIC) Drug Sales by Country (2021-2026) & (K Units) Table 226. Asia Opioid Induced Constipation (OIC) Drug Sales by Country (2027-2032) & (K Units) Table 227. Asia Opioid Induced Constipation (OIC) Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 228. Asia Opioid Induced Constipation (OIC) Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 229. Japan Opioid Induced Constipation (OIC) Drug Revenue (2021-2032) & (US$ Million) Table 230. South Korea Opioid Induced Constipation (OIC) Drug Revenue (2021-2032) & (US$ Million) Table 231. India Opioid Induced Constipation (OIC) Drug Revenue (2021-2032) & (US$ Million) Table 232. Australia Opioid Induced Constipation (OIC) Drug Revenue (2021-2032) & (US$ Million) Table 233. China Taiwan Opioid Induced Constipation (OIC) Drug Revenue (2021-2032) & (US$ Million) Table 234. Southeast Asia Opioid Induced Constipation (OIC) Drug Revenue (2021-2032) & (US$ Million) Table 235. SAMEA Opioid Induced Constipation (OIC) Drug Revenue by Type (2021-2026) & (US$ Million) Table 236. SAMEA Opioid Induced Constipation (OIC) Drug Revenue by Type (2027-2032) & (US$ Million) Table 237. SAMEA Opioid Induced Constipation (OIC) Drug Sales by Type (2021-2026) & (K Units) Table 238. SAMEA Opioid Induced Constipation (OIC) Drug Sales by Type (2027-2032) & (K Units) Table 239. SAMEA Opioid Induced Constipation (OIC) Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 240. SAMEA Opioid Induced Constipation (OIC) Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 241. SAMEA Opioid Induced Constipation (OIC) Drug Revenue by Application (2021-2026) & (US$ Million) Table 242. SAMEA Opioid Induced Constipation (OIC) Drug Revenue by Application (2027-2032) & (US$ Million) Table 243. SAMEA Opioid Induced Constipation (OIC) Drug Sales by Application (2021-2026) & (K Units) Table 244. SAMEA Opioid Induced Constipation (OIC) Drug Sales by Application (2027-2032) & (K Units) Table 245. SAMEA Opioid Induced Constipation (OIC) Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 246. SAMEA Opioid Induced Constipation (OIC) Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 247. SAMEA Opioid Induced Constipation (OIC) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 248. SAMEA Opioid Induced Constipation (OIC) Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 249. SAMEA Opioid Induced Constipation (OIC) Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 250. SAMEA Opioid Induced Constipation (OIC) Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 251. SAMEA Opioid Induced Constipation (OIC) Drug Sales by Country (2021-2026) & (K Units) Table 252. SAMEA Opioid Induced Constipation (OIC) Drug Sales by Country (2027-2032) & (K Units) Table 253. SAMEA Opioid Induced Constipation (OIC) Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 254. SAMEA Opioid Induced Constipation (OIC) Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 255. Brazil Opioid Induced Constipation (OIC) Drug Revenue (2021-2032) & (US$ Million) Table 256. Argentina Opioid Induced Constipation (OIC) Drug Revenue (2021-2032) & (US$ Million) Table 257. Chile Opioid Induced Constipation (OIC) Drug Revenue (2021-2032) & (US$ Million) Table 258. Colombia Opioid Induced Constipation (OIC) Drug Revenue (2021-2032) & (US$ Million) Table 259. Peru Opioid Induced Constipation (OIC) Drug Revenue (2021-2032) & (US$ Million) Table 260. Saudi Arabia Opioid Induced Constipation (OIC) Drug Revenue (2021-2032) & (US$ Million) Table 261. Israel Opioid Induced Constipation (OIC) Drug Revenue (2021-2032) & (US$ Million) Table 262. UAE Opioid Induced Constipation (OIC) Drug Revenue (2021-2032) & (US$ Million) Table 263. Turkey Opioid Induced Constipation (OIC) Drug Revenue (2021-2032) & (US$ Million) Table 264. Iran Opioid Induced Constipation (OIC) Drug Revenue (2021-2032) & (US$ Million) Table 265. Egypt Opioid Induced Constipation (OIC) Drug Revenue (2021-2032) & (US$ Million) Table 266. Key Raw Materials Table 267. Raw Materials Key Suppliers Table 268. Opioid Induced Constipation (OIC) Drug Distributors List Table 269. Opioid Induced Constipation (OIC) Drug Customers List Table 270. Research Programs/Design for This Report Table 271. Authors List of This Report Table 272. Secondary Sources Table 273. Primary Sources List of Figures Figure 1. Opioid Induced Constipation (OIC) Drug Image Figure 2. Global Opioid Induced Constipation (OIC) Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Opioid Induced Constipation (OIC) Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Naldemedine Image Figure 5. Lubiprostone Image Figure 6. Methyl Naltrexone Bromide Image Figure 7. Alvimopan Image Figure 8. Other Image Figure 9. Global Opioid Induced Constipation (OIC) Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Opioid Induced Constipation (OIC) Drug Market Size Share 2021 VS 2025 VS 2032 Figure 11. Retail Pharmacies Image Figure 12. Online Pharmacies Image Figure 13. Hospital Pharmacies Image Figure 14. Global Opioid Induced Constipation (OIC) Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Opioid Induced Constipation (OIC) Drug Revenue (2021-2032) & (US$ Million) Figure 16. Global Opioid Induced Constipation (OIC) Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region (2021-2032) Figure 19. Global Opioid Induced Constipation (OIC) Drug Sales (2021-2032) & (K Units) Figure 20. Global Opioid Induced Constipation (OIC) Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 21. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Opioid Induced Constipation (OIC) Drug Sales YoY (2021-2032) & (K Units) Figure 23. Europe Opioid Induced Constipation (OIC) Drug Sales YoY (2021-2032) & (K Units) Figure 24. China Opioid Induced Constipation (OIC) Drug Sales YoY (2021-2032) & (K Units) Figure 25. Asia (Excluding China) Opioid Induced Constipation (OIC) Drug Sales YoY (2021-2032) & (K Units) Figure 26. South America, Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales YoY (2021-2032) & (K Units) Figure 27. Global Opioid Induced Constipation (OIC) Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Opioid Induced Constipation (OIC) Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Opioid Induced Constipation (OIC) Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type (2021-2032) Figure 33. Global Opioid Induced Constipation (OIC) Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 34. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2021-2032) Figure 36. Global Opioid Induced Constipation (OIC) Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Application (2021-2032) Figure 39. Global Opioid Induced Constipation (OIC) Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 40. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2021-2032) Figure 42. North America Opioid Induced Constipation (OIC) Drug Revenue Share by Type (2021-2032) Figure 43. North America Opioid Induced Constipation (OIC) Drug Sales Share by Type (2021-2032) Figure 44. North America Opioid Induced Constipation (OIC) Drug Revenue Share by Application (2021-2032) Figure 45. North America Opioid Induced Constipation (OIC) Drug Sales Share by Application (2021-2032) Figure 46. North America Opioid Induced Constipation (OIC) Drug Revenue Share by Country (2021-2032) Figure 47. North America Opioid Induced Constipation (OIC) Drug Sales Share by Country (2021-2032) Figure 48. Europe Opioid Induced Constipation (OIC) Drug Revenue Share by Type (2021-2032) Figure 49. Europe Opioid Induced Constipation (OIC) Drug Sales Share by Type (2021-2032) Figure 50. Europe Opioid Induced Constipation (OIC) Drug Revenue Share by Application (2021-2032) Figure 51. Europe Opioid Induced Constipation (OIC) Drug Sales Share by Application (2021-2032) Figure 52. Europe Opioid Induced Constipation (OIC) Drug Revenue Share by Country (2021-2032) Figure 53. Europe Opioid Induced Constipation (OIC) Drug Sales Share by Country (2021-2032) Figure 54. China Opioid Induced Constipation (OIC) Drug Revenue Share by Type (2021-2032) Figure 55. China Opioid Induced Constipation (OIC) Drug Sales Share by Type (2021-2032) Figure 56. China Opioid Induced Constipation (OIC) Drug Revenue Share by Application (2021-2032) Figure 57. China Opioid Induced Constipation (OIC) Drug Sales Share by Application (2021-2032) Figure 58. Asia Opioid Induced Constipation (OIC) Drug Revenue Share by Type (2021-2032) Figure 59. Asia Opioid Induced Constipation (OIC) Drug Sales Share by Type (2021-2032) Figure 60. Asia Opioid Induced Constipation (OIC) Drug Revenue Share by Application (2021-2032) Figure 61. Asia Opioid Induced Constipation (OIC) Drug Sales Share by Application (2021-2032) Figure 62. Asia Opioid Induced Constipation (OIC) Drug Revenue Share by Country (2021-2032) Figure 63. Asia Opioid Induced Constipation (OIC) Drug Sales Share by Country (2021-2032) Figure 64. SAMEA Opioid Induced Constipation (OIC) Drug Revenue Share by Type (2021-2032) Figure 65. SAMEA Opioid Induced Constipation (OIC) Drug Sales Share by Type (2021-2032) Figure 66. SAMEA Opioid Induced Constipation (OIC) Drug Revenue Share by Application (2021-2032) Figure 67. SAMEA Opioid Induced Constipation (OIC) Drug Sales Share by Application (2021-2032) Figure 68. SAMEA Opioid In

Scope & coverage.

Types
  • Naldemedine
  • Lubiprostone
  • Methyl Naltrexone Bromide
  • Alvimopan
  • Other
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Allergan
  • Bausch Health
  • C.B. Fleet Company
  • Cosmo Pharmaceuticals SA
  • Daewoong Pharmaceutical
  • Daiichi Sankyo Co
  • Ironwood Pharmaceuticals
  • Mundipharma International Limited
  • Nektar Therapeutics
  • Ono Pharmaceutical
  • Progenics Pharmaceuticals
  • Purdue Pharma
  • S.L.A. Pharma
  • Shionogi &
  • Sucampo Pharmaceuticals
  • Theravance Biopharma
  • Pfizer
  • Takeda Pharmaceutical Company Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Opioid Induced Constipation (OIC) Drug Market by Type
  3. 1.2.1 Global Opioid Induced Constipation (OIC) Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Naldemedine
  5. 1.2.3 Lubiprostone
  6. 1.2.4 Methyl Naltrexone Bromide
  7. 1.2.5 Alvimopan
  8. 1.2.6 Other
  9. 1.3 Opioid Induced Constipation (OIC) Drug Market by Application
  10. 1.3.1 Global Opioid Induced Constipation (OIC) Drug Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Retail Pharmacies
  12. 1.3.3 Online Pharmacies
  13. 1.3.4 Hospital Pharmacies
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Opioid Induced Constipation (OIC) Drug Market Dynamics
  1. 2.1 Opioid Induced Constipation (OIC) Drug Industry Trends
  2. 2.2 Opioid Induced Constipation (OIC) Drug Industry Drivers
  3. 2.3 Opioid Induced Constipation (OIC) Drug Industry Opportunities and Challenges
  4. 2.4 Opioid Induced Constipation (OIC) Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Opioid Induced Constipation (OIC) Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Region
  3. 3.2.1 Global Opioid Induced Constipation (OIC) Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Opioid Induced Constipation (OIC) Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Opioid Induced Constipation (OIC) Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Opioid Induced Constipation (OIC) Drug Sales by Region
  9. 3.4.1 Global Opioid Induced Constipation (OIC) Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Opioid Induced Constipation (OIC) Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Opioid Induced Constipation (OIC) Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Opioid Induced Constipation (OIC) Drug Revenue by Manufacturers
  2. 4.1.1 Global Opioid Induced Constipation (OIC) Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Opioid Induced Constipation (OIC) Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Opioid Induced Constipation (OIC) Drug Sales by Manufacturers
  6. 4.2.1 Global Opioid Induced Constipation (OIC) Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Opioid Induced Constipation (OIC) Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Opioid Induced Constipation (OIC) Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Opioid Induced Constipation (OIC) Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Opioid Induced Constipation (OIC) Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Opioid Induced Constipation (OIC) Drug Manufacturers, Product Type & Application
  13. 4.7 Global Opioid Induced Constipation (OIC) Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Opioid Induced Constipation (OIC) Drug Market CR5 and HHI
  16. 4.8.2 2025 Opioid Induced Constipation (OIC) Drug Tier 1, Tier 2, and Tier 3
5 Opioid Induced Constipation (OIC) Drug Market by Type
  1. 5.1 Global Opioid Induced Constipation (OIC) Drug Revenue by Type
  2. 5.1.1 Global Opioid Induced Constipation (OIC) Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Opioid Induced Constipation (OIC) Drug Sales by Type
  6. 5.2.1 Global Opioid Induced Constipation (OIC) Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Opioid Induced Constipation (OIC) Drug Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Opioid Induced Constipation (OIC) Drug Price by Type
6 Opioid Induced Constipation (OIC) Drug Market by Application
  1. 6.1 Global Opioid Induced Constipation (OIC) Drug Revenue by Application
  2. 6.1.1 Global Opioid Induced Constipation (OIC) Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Opioid Induced Constipation (OIC) Drug Sales by Application
  6. 6.2.1 Global Opioid Induced Constipation (OIC) Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Opioid Induced Constipation (OIC) Drug Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Opioid Induced Constipation (OIC) Drug Price by Application
7 Company Profiles
  1. 7.1 Allergan
  2. 7.1.1 Allergan Company Information
  3. 7.1.2 Allergan Business Overview
  4. 7.1.3 Allergan Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Allergan Opioid Induced Constipation (OIC) Drug Product Portfolio
  6. 7.1.5 Allergan Recent Developments
  7. 7.2 Bausch Health
  8. 7.2.1 Bausch Health Company Information
  9. 7.2.2 Bausch Health Business Overview
  10. 7.2.3 Bausch Health Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Bausch Health Opioid Induced Constipation (OIC) Drug Product Portfolio
  12. 7.2.5 Bausch Health Recent Developments
  13. 7.3 C.B. Fleet Company
  14. 7.3.1 C.B. Fleet Company Company Information
  15. 7.3.2 C.B. Fleet Company Business Overview
  16. 7.3.3 C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Product Portfolio
  18. 7.3.5 C.B. Fleet Company Recent Developments
  19. 7.4 Cosmo Pharmaceuticals SA
  20. 7.4.1 Cosmo Pharmaceuticals SA Company Information
  21. 7.4.2 Cosmo Pharmaceuticals SA Business Overview
  22. 7.4.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Product Portfolio
  24. 7.4.5 Cosmo Pharmaceuticals SA Recent Developments
  25. 7.5 Daewoong Pharmaceutical
  26. 7.5.1 Daewoong Pharmaceutical Company Information
  27. 7.5.2 Daewoong Pharmaceutical Business Overview
  28. 7.5.3 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Portfolio
  30. 7.5.5 Daewoong Pharmaceutical Recent Developments
  31. 7.6 Daiichi Sankyo Co
  32. 7.6.1 Daiichi Sankyo Co Company Information
  33. 7.6.2 Daiichi Sankyo Co Business Overview
  34. 7.6.3 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Product Portfolio
  36. 7.6.5 Daiichi Sankyo Co Recent Developments
  37. 7.7 Ironwood Pharmaceuticals
  38. 7.7.1 Ironwood Pharmaceuticals Company Information
  39. 7.7.2 Ironwood Pharmaceuticals Business Overview
  40. 7.7.3 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Portfolio
  42. 7.7.5 Ironwood Pharmaceuticals Recent Developments
  43. 7.8 Mundipharma International Limited
  44. 7.8.1 Mundipharma International Limited Company Information
  45. 7.8.2 Mundipharma International Limited Business Overview
  46. 7.8.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Product Portfolio
  48. 7.8.5 Mundipharma International Limited Recent Developments
  49. 7.9 Nektar Therapeutics
  50. 7.9.1 Nektar Therapeutics Company Information
  51. 7.9.2 Nektar Therapeutics Business Overview
  52. 7.9.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Product Portfolio
  54. 7.9.5 Nektar Therapeutics Recent Developments
  55. 7.10 Ono Pharmaceutical
  56. 7.10.1 Ono Pharmaceutical Company Information
  57. 7.10.2 Ono Pharmaceutical Business Overview
  58. 7.10.3 Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Portfolio
  60. 7.10.5 Ono Pharmaceutical Recent Developments
  61. 7.11 Progenics Pharmaceuticals
  62. 7.11.1 Progenics Pharmaceuticals Company Information
  63. 7.11.2 Progenics Pharmaceuticals Business Overview
  64. 7.11.3 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Portfolio
  66. 7.11.5 Progenics Pharmaceuticals Recent Developments
  67. 7.12 Purdue Pharma
  68. 7.12.1 Purdue Pharma Company Information
  69. 7.12.2 Purdue Pharma Business Overview
  70. 7.12.3 Purdue Pharma Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Purdue Pharma Opioid Induced Constipation (OIC) Drug Product Portfolio
  72. 7.12.5 Purdue Pharma Recent Developments
  73. 7.13 S.L.A. Pharma
  74. 7.13.1 S.L.A. Pharma Company Information
  75. 7.13.2 S.L.A. Pharma Business Overview
  76. 7.13.3 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Product Portfolio
  78. 7.13.5 S.L.A. Pharma Recent Developments
  79. 7.14 Shionogi &
  80. 7.14.1 Shionogi & Company Information
  81. 7.14.2 Shionogi & Business Overview
  82. 7.14.3 Shionogi & Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Shionogi & Opioid Induced Constipation (OIC) Drug Product Portfolio
  84. 7.14.5 Shionogi & Recent Developments
  85. 7.15 Sucampo Pharmaceuticals
  86. 7.15.1 Sucampo Pharmaceuticals Company Information
  87. 7.15.2 Sucampo Pharmaceuticals Business Overview
  88. 7.15.3 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Portfolio
  90. 7.15.5 Sucampo Pharmaceuticals Recent Developments
  91. 7.16 Theravance Biopharma
  92. 7.16.1 Theravance Biopharma Company Information
  93. 7.16.2 Theravance Biopharma Business Overview
  94. 7.16.3 Theravance Biopharma Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Theravance Biopharma Opioid Induced Constipation (OIC) Drug Product Portfolio
  96. 7.16.5 Theravance Biopharma Recent Developments
  97. 7.17 Pfizer
  98. 7.17.1 Pfizer Company Information
  99. 7.17.2 Pfizer Business Overview
  100. 7.17.3 Pfizer Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Pfizer Opioid Induced Constipation (OIC) Drug Product Portfolio
  102. 7.17.5 Pfizer Recent Developments
  103. 7.18 Takeda Pharmaceutical Company Limited
  104. 7.18.1 Takeda Pharmaceutical Company Limited Company Information
  105. 7.18.2 Takeda Pharmaceutical Company Limited Business Overview
  106. 7.18.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Product Portfolio
  108. 7.18.5 Takeda Pharmaceutical Company Limited Recent Developments
8 North America
  1. 8.1 North America Opioid Induced Constipation (OIC) Drug Market Size by Type
  2. 8.1.1 North America Opioid Induced Constipation (OIC) Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Opioid Induced Constipation (OIC) Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Opioid Induced Constipation (OIC) Drug Price by Type (2021-2032)
  5. 8.2 North America Opioid Induced Constipation (OIC) Drug Market Size by Application
  6. 8.2.1 North America Opioid Induced Constipation (OIC) Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Opioid Induced Constipation (OIC) Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Opioid Induced Constipation (OIC) Drug Price by Application (2021-2032)
  9. 8.3 North America Opioid Induced Constipation (OIC) Drug Market Size by Country
  10. 8.3.1 North America Opioid Induced Constipation (OIC) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Opioid Induced Constipation (OIC) Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Opioid Induced Constipation (OIC) Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Opioid Induced Constipation (OIC) Drug Market Size by Type
  2. 9.1.1 Europe Opioid Induced Constipation (OIC) Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Opioid Induced Constipation (OIC) Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Opioid Induced Constipation (OIC) Drug Price by Type (2021-2032)
  5. 9.2 Europe Opioid Induced Constipation (OIC) Drug Market Size by Application
  6. 9.2.1 Europe Opioid Induced Constipation (OIC) Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Opioid Induced Constipation (OIC) Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Opioid Induced Constipation (OIC) Drug Price by Application (2021-2032)
  9. 9.3 Europe Opioid Induced Constipation (OIC) Drug Market Size by Country
  10. 9.3.1 Europe Opioid Induced Constipation (OIC) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Opioid Induced Constipation (OIC) Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Opioid Induced Constipation (OIC) Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Opioid Induced Constipation (OIC) Drug Market Size by Type
  2. 10.1.1 China Opioid Induced Constipation (OIC) Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Opioid Induced Constipation (OIC) Drug Sales by Type (2021-2032)
  4. 10.1.3 China Opioid Induced Constipation (OIC) Drug Price by Type (2021-2032)
  5. 10.2 China Opioid Induced Constipation (OIC) Drug Market Size by Application
  6. 10.2.1 China Opioid Induced Constipation (OIC) Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Opioid Induced Constipation (OIC) Drug Sales by Application (2021-2032)
  8. 10.2.3 China Opioid Induced Constipation (OIC) Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Opioid Induced Constipation (OIC) Drug Market Size by Type
  2. 11.1.1 Asia Opioid Induced Constipation (OIC) Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Opioid Induced Constipation (OIC) Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Opioid Induced Constipation (OIC) Drug Price by Type (2021-2032)
  5. 11.2 Asia Opioid Induced Constipation (OIC) Drug Market Size by Application
  6. 11.2.1 Asia Opioid Induced Constipation (OIC) Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Opioid Induced Constipation (OIC) Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Opioid Induced Constipation (OIC) Drug Price by Application (2021-2032)
  9. 11.3 Asia Opioid Induced Constipation (OIC) Drug Market Size by Country
  10. 11.3.1 Asia Opioid Induced Constipation (OIC) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Opioid Induced Constipation (OIC) Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Opioid Induced Constipation (OIC) Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Opioid Induced Constipation (OIC) Drug Market Size by Type
  2. 12.1.1 SAMEA Opioid Induced Constipation (OIC) Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Opioid Induced Constipation (OIC) Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Opioid Induced Constipation (OIC) Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Opioid Induced Constipation (OIC) Drug Market Size by Application
  6. 12.2.1 SAMEA Opioid Induced Constipation (OIC) Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Opioid Induced Constipation (OIC) Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Opioid Induced Constipation (OIC) Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Opioid Induced Constipation (OIC) Drug Market Size by Country
  10. 12.3.1 SAMEA Opioid Induced Constipation (OIC) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Opioid Induced Constipation (OIC) Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Opioid Induced Constipation (OIC) Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Opioid Induced Constipation (OIC) Drug Value Chain Analysis
  2. 13.1.1 Opioid Induced Constipation (OIC) Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Opioid Induced Constipation (OIC) Drug Production Mode & Process
  6. 13.2 Opioid Induced Constipation (OIC) Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Opioid Induced Constipation (OIC) Drug Distributors
  9. 13.2.3 Opioid Induced Constipation (OIC) Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst